IP Library Granted Patent US 12,303,672
Granted Patent B1
US 12,303,672 · App. 19/028,890 · Granted May 20, 2025

Drug delivery device with feedback mechanism

Inventors: Thomas Mark Kemp (Ashwell, GB); Hugo Revellat (Royston, GB)
Assignee: Sanofi-Aventis Deutschland GmbH
A61M5/3157A61M5/2033A61M5/3245A61M2005/208A61M2005/3247A61M2005/3267A61M2205/581A61M2205/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,303,672
App. No.
19/028,890
Granted
May 20, 2025
Kind
B1
Abstract

The disclosure relates to a drug delivery device comprising: a case adapted to hold a medicament container, a plunger disposed within the case and slidable from a proximal position into a distal position for delivering a medicament from the medicament container, at least one feedback mechanism that is in operative connection with the plunger, the feedback mechanism comprising a collar, a control spring biasing the collar in a distal direction, a needle shroud, operatively axially abutting the collar in a first coupled state and prevented from axially decoupling the collar by the plunger in its proximal position, wherein the plunger, when approaching the distal position during movement from the proximal position towards the distal position, is adapted to allow axial decoupling of the needle shroud from the collar, thus allowing for a limited axial movement of the collar relative to the needle shroud until the collar axially abuts the needle shroud in a second coupled state.

Claims (55)

1. An autoinjector comprising:

a plunger movable along a longitudinal axis of the autoinjector in a distal direction between a first plunger position and a drug delivery position to deliver a medicament from a syringe of the autoinjector;

an inner sleeve comprising an inner sleeve body;

a flexible arm extending from the inner sleeve body, wherein the flexible arm is movable relative to the inner sleeve body between an inwardly deflected position and a relaxed position, wherein a portion of the flexible arm extends outwardly relative to the inner sleeve body in the relaxed position;

an outer sleeve disposed at a proximal portion of the autoinjector, the outer sleeve comprising an outer sleeve body having an opening radially extending through the outer sleeve body, wherein the opening is sized to receive the portion of the flexible arm when the flexible arm is in the relaxed position;

a release member configured to move from (a) a first position in which a proximal end of the inner sleeve engages a latch on a proximal end of the plunger to hold the plunger in the first plunger position, toward the outer sleeve to (b) a second position in which the inner sleeve has disengaged from the latch of the plunger to allow the plunger to move in the distal direction from a second position to the drug delivery position; and

a control spring movable between a compressed state and an expanded state, wherein the control spring is configured to transition to the expanded state after the plunger moves to the drug delivery position,

wherein the autoinjector is configured such that as the control spring transitions to the expanded state, the inner sleeve is configured to move within the outer sleeve to allow the flexible arm to

(i) engage the outer sleeve with the portion of the flexible arm,

(ii) inwardly deflect from the relaxed position to the inwardly deflected position, and

(iii) remain in the inwardly deflected position until the portion of the flexible arm disengages from the outer sleeve and the flexible arm moves into the relaxed position,

wherein the inner sleeve is configured to generate an audible signal or a tactile signal to indicate completion of dispensing of the medicament when the flexible arm meets the outer sleeve.

2. The autoinjector of claim 1 , comprising the syringe containing the medicament, wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

3. The autoinjector of claim 1 , wherein the portion of the flexible arm comprises an angled surface that is configured to engage a first surface of the outer sleeve when the flexible arm moves from the inwardly deflected position into the relaxed position.

4. The autoinjector of claim 3 , wherein the portion of the flexible arm comprises a transversal surface that is configured to engage with a second surface of the outer sleeve after the flexible arm moves into the relaxed position.

5. The autoinjector of claim 1 , comprising a needle coupled to a distal end of the syringe, wherein the needle is movable between a (i) retracted position in which a distal tip of the needle is proximal to a distal end of the autoinjector, and (ii) an injection position in which the distal tip is distal to the distal end of the autoinjector.

6. The autoinjector of claim 5 , wherein the autoinjector is configured such that when the plunger is in the first plunger position, the needle is in the retracted position, and when the plunger moves away from the first plunger position, the needle moves into the injection position.

7. The autoinjector of claim 1 , comprising a drive spring having (i) a distal end in direct engagement with the plunger for moving the plunger in a distal direction and (ii) a proximal end held in a fixed axial location as the plunger moves in the distal direction.

8. The autoinjector of claim 1 , wherein the inner sleeve is configured to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament when the portion of the flexible arm is disposed in the opening of the outer sleeve body.

9. The autoinjector of claim 1 , wherein the outer sleeve remains in a fixed axial location as the plunger moves into the drug delivery position.

10. The autoinjector of claim 1 , wherein the autoinjector is configured such that the outer sleeve and the plunger rotate relative to each other before the plunger moves into the drug delivery position.

11. An autoinjector comprising:

a plunger movable in a distal direction to deliver a medicament from a syringe of the autoinjector;

an inner sleeve comprising an inner sleeve body;

a flexible arm extending from the inner sleeve body, wherein the flexible arm is movable relative to the inner sleeve body between an inwardly deflected position and a relaxed position, wherein a portion of the flexible arm extends outwardly relative to the inner sleeve body in the relaxed position;

an outer sleeve comprising an outer sleeve body having an opening radially extending through a distal portion of the outer sleeve body;

a release member configured to move from (a) a first position in which a proximal end of the inner sleeve engages a latch on a proximal end of the plunger to hold the plunger in a first plunger position, toward the outer sleeve to (b) a second position in which the inner sleeve has disengaged from the latch of the plunger to allow the plunger to move through the inner sleeve and into a drug delivery position; and

a control spring configured to move the inner sleeve within the outer sleeve such that (i) the flexible arm inwardly deflects from the relaxed position into the inwardly deflected position, and (ii) the flexible arm remains in the inwardly deflected position until the portion of the flexible arm disengages from the outer sleeve to allow the flexible arm to move into the relaxed position, and

wherein the inner sleeve is configured to generate an audible signal or a tactile signal to indicate completion of dispensing of the medicament when the flexible arm impacts the outer sleeve.

12. The autoinjector of claim 11 , wherein the outer sleeve is disposed at a proximal portion of the autoinjector.

13. The autoinjector of claim 11 , wherein the inner sleeve is configured to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament when the portion of the flexible arm is disposed in the opening of the outer sleeve body.

14. The autoinjector of claim 11 , comprising the syringe containing the medicament, wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

15. The autoinjector of claim 11 , wherein the portion of the flexible arm comprises an angled surface that is configured to engage a first surface of the outer sleeve when the flexible arm moves from the inwardly deflected position into the relaxed position.

16. The autoinjector of claim 15 , wherein the portion of the flexible arm comprises a transversal surface that is configured to engage with a second surface of the outer sleeve after the flexible arm moves into the relaxed position.

17. The autoinjector of claim 11 , comprising a needle coupled to a distal end of the syringe, wherein the needle is movable between a (i) retracted position in which a distal tip of the needle is proximal to a distal end of the autoinjector, and (ii) an injection position in which the distal tip is distal to the distal end of the autoinjector.

18. The autoinjector of claim 17 , wherein the autoinjector is configured such that when the plunger is in the first plunger position, the needle is in the retracted position, and when the plunger moves away from the first plunger position, the needle moves into the injection position.

19. The autoinjector of claim 11 , comprising a drive spring having (i) a distal end in direct engagement with the plunger for moving the plunger in a distal direction and (ii) a proximal end held in a fixed axial location as the plunger moves in the distal direction.

20. The autoinjector of claim 19 , wherein a diameter of the control spring is larger than a diameter of the drive spring.

21. The autoinjector of claim 11 , wherein the outer sleeve remains in a fixed axial location as the plunger moves into the drug delivery position.

22. The autoinjector of claim 11 , wherein the autoinjector is configured such that the outer sleeve and the plunger rotate relative to each other before the plunger is in the drug delivery position.

23. The autoinjector of claim 11 , wherein the control spring is movable between a compressed state and an expanded state, wherein the control spring is configured to transition to the expanded state after the plunger moves to the drug delivery position.

24. A drug delivery device comprising:

a plunger movable in a distal direction to deliver a medicament from a medicament container of the drug delivery device;

an inner sleeve comprising an inner sleeve body, the inner sleeve configured to engage with a proximal end of the plunger;

a flexible arm extending from the inner sleeve body, wherein the flexible arm is movable relative to the inner sleeve body between an inwardly deflected position and a relaxed position, wherein a portion of the flexible arm extends outwardly relative to the inner sleeve body in the relaxed position;

an outer sleeve comprising an outer sleeve body having an opening radially extending through a distal portion of the outer sleeve body;

a release member configured to move toward the outer sleeve and release the proximal end of the plunger from engagement with the inner sleeve to allow the plunger to move in the distal direction and through the inner sleeve and into a drug delivery position; and

a control spring configured to move the inner sleeve within the outer sleeve such that (i) the flexible arm inwardly deflects from the relaxed position into the inwardly deflected position, and (ii) the flexible arm remains in the inwardly deflected position until the portion of the flexible arm disengages from the outer sleeve to allow the flexible arm to move into the relaxed position,

wherein the inner sleeve is configured to generate an audible signal or a tactile signal to indicate completion of dispensing of the medicament.

25. The drug delivery device of claim 24 , wherein the release member is configured to move from a first position in which a proximal end of the inner sleeve engages a latch on the proximal end of the plunger to hold the plunger in a first plunger position.

26. The drug delivery device of claim 25 , wherein the release member is configured to move from the first position toward the outer sleeve to a second position in which the inner sleeve has disengaged from the latch of the plunger to allow the plunger to move to the drug delivery position.

27. The drug delivery device of claim 24 , wherein the inner sleeve is configured to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament when the flexible arm impacts the outer sleeve body.

28. The drug delivery device of claim 24 , comprising the medicament container containing the medicament, wherein the medicament comprises a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

29. The drug delivery device of claim 24 , wherein the portion of the flexible arm comprises an angled surface that is configured to engage a first surface of the outer sleeve when the flexible arm moves from the inwardly deflected position into the relaxed position.

30. The drug delivery device of claim 24 , wherein the portion of the flexible arm comprises a transversal surface that is configured to engage with a second surface of the outer sleeve after the flexible arm moves into the relaxed position.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2025
From: KEMP, THOMAS MARK; REVELLAT, HUGO
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 070516/0618 →
Priority Claims (1)
EP 15170590 · Jun 3, 2015 · regional
Continuity (3)
Continuation 18968712 · Dec 4, 2024
Continuation 17172602 · Feb 10, 2021
Continuation 15578668
References Cited (199)
US 4629454A · Grier · 1986 [cited by applicant]
US 4693711A · Bremer et al. · 1987 [cited by applicant]
US 4810249A · Haber et al. · 1989 [cited by applicant]
US 5114406A · Gabriel et al. · 1992 [cited by applicant]
US 5116313A · McGregor · 1992 [cited by applicant]
US 5127906A · Landry et al. · 1992 [cited by applicant]
US 5271527A · Haber et al. · 1993 [cited by applicant]
US 5391157A · Harris et al. · 1995 [cited by applicant]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 7611495B1 · Gianturco · 2009 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 8979807B2 · Grunhut et al. · 2015 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9168339B2 · Cowe · 2015 [cited by applicant]
US 9199038B2 · Daniel · 2015 [cited by applicant]
US 9216251B2 · Daniel · 2015 [cited by applicant]
US 9216256B2 · Olson et al. · 2015 [cited by applicant]
US 9233213B2 · Olson et al. · 2016 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9744306B2 · Cowe · 2017 [cited by applicant]
US 9764096B2 · Maritan · 2017 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 10569019B2 · Hirschel et al. · 2020 [cited by applicant]
US 10799647B2 · Hostettler et al. · 2020 [cited by applicant]
US 10888668B2 · Mosebach et al. · 2021 [cited by applicant]
US 10918811B2 · Mosebach et al. · 2021 [cited by applicant]
US 10926032B2 · Mosebach et al. · 2021 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11357922B2 · Mosebach et al. · 2022 [cited by applicant]
US 11383044B2 · Tschirren et al. · 2022 [cited by applicant]
US 11400232B2 · Schader et al. · 2022 [cited by applicant]
US 11452821B2 · LaFever et al. · 2022 [cited by applicant]
US 11654246B2 · Revellat et al. · 2023 [cited by applicant]
US 12102812B2 · Mosebach et al. · 2024 [cited by applicant]
US 12156994B2 · Mosebach et al. · 2024 [cited by applicant]
US 12179000B2 · Mosebach et al. · 2024 [cited by applicant]
US 20020188247A1 · Peery · 2002 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20040210199A1 · Atterbury et al. · 2004 [cited by applicant]
US 20050027255A1 · Lavi et al. · 2005 [cited by applicant]
US 20050038392A1 · DeSalvo · 2005 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20070088248A1 · Glenn et al. · 2007 [cited by applicant]
US 20080021373A1 · Rosati · 2008 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20100198182A1 · Lanigan et al. · 2010 [cited by applicant]
US 20110026721A1 · Parker · 2011 [cited by applicant]
US 20110105952A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110238014A1 · Maritan · 2011 [cited by applicant]
US 20130023749A1 · Afanasewicz et al. · 2013 [cited by applicant]
US 20130090605A1 · O'Connor et al. · 2013 [cited by applicant]
US 20130131595A1 · Ekman et al. · 2013 [cited by applicant]
US 20130211330A1 · Pedersen et al. · 2013 [cited by applicant]
US 20130317427A1 · Brereton et al. · 2013 [cited by applicant]
US 20130324925A1 · Brereton et al. · 2013 [cited by applicant]
US 20130345642A1 · Cowe · 2013 [cited by applicant]
US 20140114250A1 · DeSalvo et al. · 2014 [cited by applicant]
US 20140243751A1 · Brereton et al. · 2014 [cited by applicant]
US 20140243757A1 · Dasbach et al. · 2014 [cited by applicant]
US 20140276568A1 · Worden et al. · 2014 [cited by applicant]
US 20140343527A1 · Scarpine et al. · 2014 [cited by applicant]
US 20150265772A1 · Maritan · 2015 [cited by applicant]
US 20150320939A1 · Beek et al. · 2015 [cited by applicant]
US 20160008541A1 · Hirschel et al. · 2016 [cited by applicant]
US 20160008542A1 · Hirschel et al. · 2016 [cited by applicant]
US 20160015899A1 · Plumptre et al. · 2016 [cited by applicant]
US 20160144133A1 · Kemp · 2016 [cited by applicant]
US 20160361503A1 · Bendek et al. · 2016 [cited by applicant]
US 20170136173A1 · Melander et al. · 2017 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20180154078A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180154085A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180154089A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180169342A1 · Mosebach et al. · 2018 [cited by applicant]
US 20190374717A1 · Swanson et al. · 2019 [cited by applicant]
US 20200289764A1 · Revellat et al. · 2020 [cited by applicant]
US 20210093790A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210128837A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210170115A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210369966A1 · Schader et al. · 2021 [cited by applicant]
US 20220257865A1 · Mosebach et al. · 2022 [cited by applicant]
US 20220305206A1 · Schader et al. · 2022 [cited by applicant]
US 20230277777A1 · Revellat et al. · 2023 [cited by applicant]
US 20240416051A1 · Mosebach et al. · 2024 [cited by applicant]
CN 200987443Y · 2007 [cited by applicant]
CN 101107032A · 2008 [cited by applicant]
CN 201111673Y · 2008 [cited by applicant]
CN 201243374Y · 2009 [cited by applicant]
CN 102209564A · 2011 [cited by applicant]
CN 102665801A · 2012 [cited by applicant]
CN 102842236A · 2012 [cited by applicant]
CN 202887394U · 2013 [cited by applicant]
CN 103177716A · 2013 [cited by applicant]
CN 103235538A · 2013 [cited by applicant]
CN 103974733A · 2014 [cited by applicant]
CN 104023769A · 2014 [cited by applicant]
CN 104080499A · 2014 [cited by applicant]
CN 104519929A · 2015 [cited by applicant]
CN 105188809A · 2015 [cited by applicant]
CN 105327432A · 2016 [cited by applicant]
CN 105451792A · 2016 [cited by applicant]
CN 106573114A · 2017 [cited by applicant]
DE 7833454U1 · 1979 [cited by applicant]
DE 3935672A1 · 1990 [cited by applicant]
EP 2583705A1 · 2013 [cited by applicant]
EP 2722065A1 · 2014 [cited by applicant]
EP 2727617A1 · 2014 [cited by applicant]
EP 2823841A1 · 2015 [cited by applicant]
EP 2868338A1 · 2015 [cited by applicant]
EP 3302632A1 · 2020 [cited by applicant]
JP H05508098A · 1993 [cited by applicant]
JP H06190041A · 1994 [cited by applicant]
JP H07509636A · 1995 [cited by applicant]
JP 2005508205A · 2005 [cited by applicant]
JP 2011519712A · 2011 [cited by applicant]
JP 2012504006A · 2012 [cited by applicant]
JP 2013526894A · 2013 [cited by applicant]
JP 2013526904A · 2013 [cited by applicant]
JP 2013146600A · 2013 [cited by applicant]
JP 2013534164A · 2013 [cited by applicant]
JP 2014526298A · 2014 [cited by applicant]
JP 2014531961A · 2014 [cited by applicant]
JP 2015526215A · 2015 [cited by applicant]
JP 2015536184A · 2015 [cited by applicant]
JP 2016512766A · 2016 [cited by applicant]
JP 2016513507A · 2016 [cited by applicant]
JP 2016526460A · 2016 [cited by applicant]
JP 2016534790A · 2016 [cited by applicant]
RU 2140794C1 · 1999 [cited by applicant]
RU 2012137269A · 2014 [cited by applicant]
WO WO1992017223A1 · 1992 [cited by applicant]
WO WO1994003222A2 · 1994 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2002092153A2 · 2002 [cited by applicant]
WO WO2005046773A1 · 2005 [cited by applicant]
WO WO2006079481A1 · 2006 [cited by applicant]
WO WO2009140251A2 · 2009 [cited by applicant]
WO WO2010035057A1 · 2010 [cited by applicant]
WO WO2010136077A1 · 2010 [cited by applicant]
WO WO2011043714A1 · 2011 [cited by applicant]
WO WO2011079278A1 · 2011 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2011123024A1 · 2011 [cited by applicant]
WO WO2012022810A2 · 2012 [cited by applicant]
WO WO2012045350A1 · 2012 [cited by applicant]
WO WO2013034984A2 · 2013 [cited by applicant]
WO WO2013034985A2 · 2013 [cited by applicant]
WO WO2013050474A1 · 2013 [cited by applicant]
WO WO2013057032A1 · 2013 [cited by applicant]
WO WO2013057033A1 · 2013 [cited by applicant]
WO WO2013057034A1 · 2013 [cited by applicant]
WO WO2014005808A1 · 2014 [cited by applicant]
WO WO2014033141A1 · 2014 [cited by applicant]
WO WO2014066461A1 · 2014 [cited by applicant]
WO WO2014139914A1 · 2014 [cited by applicant]
WO WO2014139922A1 · 2014 [cited by applicant]
WO WO2014146209A1 · 2014 [cited by applicant]
WO WO2014164943A1 · 2014 [cited by applicant]
WO WO2015004049A1 · 2015 [cited by applicant]
WO WO2015004050A1 · 2015 [cited by applicant]
WO WO2015019071A1 · 2015 [cited by applicant]
WO WO2015052224A1 · 2015 [cited by applicant]
WO WO2015062915A1 · 2015 [cited by applicant]
WO WO2015074976A1 · 2015 [cited by applicant]
WO WO2016001304A1 · 2016 [cited by applicant]
WO WO2016193343A1 · 2016 [cited by applicant]
WO WO2016193344A1 · 2016 [cited by applicant]
WO WO2016193346A1 · 2016 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
U.S. Appl. No. 16/759,488, filed Apr. 27, 2020, Revellat et al. [cited by applicant]
U.S. Appl. No. 16/759,789, filed Apr. 28, 2020, Schader et al. [cited by applicant]
Engineers Edge, “Transducers USA Announced Improved TRIP60 Series of Audio Alerts,” Engineering and Technology News, Aug. 2007, 3 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062455, mailed on Dec. 5, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062449, mailed on Dec. 14, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062450, mailed on Dec. 14, 2017, 9 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062452, mailed on Dec. 14, 2017, 8 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062454, mailed on Dec. 14, 2017, 8 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2018/079915, mailed on May 14, 2020, 9 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2018/079917, mailed on May 14, 2020, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062455, mailed on Sep. 27, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062449, mailed on Aug. 17, 2016, 8 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062450, mailed on Aug. 5, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062452, mailed on Sep. 15, 2016, 11 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062454, mailed on Aug. 5, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2018/079915, mailed on Dec. 5, 2018, 10 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2018/079917, mailed on Dec. 5, 2018, 10 pages. [cited by applicant]
Karpova, “The basics of surdopedagogy,” Ekaterinburg, pp. 20-21, 2008, 7 pages (with machine translation). [cited by applicant]
National Standards of People's Republic of China, “Audible and/or Visual Fire Alarm Signaling Appliances”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Jul.… [cited by applicant]
National Standards of People's Republic of China, “Fire Detection and Alarm Systems—Smoke Alarms”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Jul. 2006, 4… [cited by applicant]
National Standards of People's Republic of China, “Vehicle Electronic Sirens”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Dec. 2014, 31 pages (with machin… [cited by applicant]
Cited By (6)
US 1,114,067 US 12,415,042 US 12,420,023 US 12,420,024 US 12,420,025 US 12,420,026